Curvo’s 2025 Clinical Products Pricing Trends Report reveals where hospitals saved — and where prices climbed — across hundreds of clinical product categories. Drawing from over 400 healthcare facilities and billions in purchasing data, this report offers a clear, data-driven view into today’s clinical marketplace.

With a US manufacturing location, embecta offers a full portfolio of safety and standard (non-safety) insulin syringes to support across the continuum of care. Learn more about embecta’s portfolio of Ultra-Fine™ insulin syringes and BD SafetyGlide™ Insulin syringes. BD is the legal manufacturer of the advertised product.

Bringing together hospital and healthcare leaders for the last 17 years. If you are a healthcare leader looking to network with other healthcare & hospital leaders we hope to see you on the road in 2025!